Dr. Aishika Datta

Qualification              : M.S. Pharm., Ph.D.

Specialization             : Pharmacology and Toxicology

E mail                         : Aishika.Datta@nmims.edu

Phone                         : 022-42332000 (Extn- 2093)

Experience                 : Industry 9 months

Interest areas:

• Neuropharmacology
• Cerebrovascular disease
• Epigenetics
• Stem cell therapy

Research

• Publications – 66
• Book Chapters- 7
• Presentations- Total number 5 (International-2, National- 3)

Conferences/Workshops/Seminars attended- 10

 Awards

• PharmInnova Award – Best PhD Thesis in Pharmacology category by Rajnibhai V. Patel Trust in association with Troikaa Pharmaceutical, 2026
• Best Oral Presentation, Stroke Symposium, 2024
• IBRO-PERC Travel grant for FENS Forum, Paris, 2022
• Senior Research Fellowship from Indian Council of Medical Research (ICMR), 2021

Recent Publications

1. Datta, A., Ghosh, B., Kumari, A., Karmarkar, G., Mukherjee, U., Dubey, A., ... & Bhattacharya, P. (2026). Mesenchymal Stem cell therapy with GHRH receptor analog resolves post-stroke vasogenic edema via modulating AQP4 and mitochondria-ER crosstalk. Journal of Translational Medicine.
2. Datta, A., Malik, N., Karmarkar, G., Barik, A., Sarmah, D., Khajekar, V., ... & Bhattacharya, P. (2026). Experimental techniques to evaluate IA-MSCs-mediated alleviation of vasogenic edema following ischemic stroke. Methods in enzymology, 733, 407-431.
3. Datta, A., Sehgal, K., Sarmah, D., Dhiman, S., Shah, B., Dhakne, P., ... & Bhattacharya, P. (2026). Stroke in persistent chronic kidney disease condition alters innate-immunity to escalate mitochondrial dysfunction and aging. npj Aging.
4. Datta, A., Patale, P., Ghosh, D., Jagtap, P., Shah, J., Katamneni, M., ... & Bhattacharya, P. (2025). Modulation of Sel1L can alleviate altered ER homeostasis towards white matter damage in CKD-stroke complex. Communications Biology, 8(1), 677.
5. Datta, A., Ghosh, B., Barik, A., Karmarkar, G., Sarmah, D., Borah, A., ... & Bhattacharya, P. (2025). Stem cell therapy modulates molecular cues of vasogenic edema following ischemic stroke: role of sirtuin-1 in regulating aquaporin-4 expression. Stem cell reviews and reports, 21(3), 797-815.
6. Datta, A., Rahane, D., Bhurle, G., Akundi, S., Mukherjee, U., Dubey, A., ... & Bhattacharya, P. (2025). Stroke in pregnancy brings epigenetic changes in correlation with affected mitochondrial dynamics and inflammasome mediated apoptosis in rodents. Journal of the American Heart Association, 14(9), e039411.
7. Datta, A., Suthar, P., Sarmah, D., Jadhav, P., Shah, J., Katamneni, M., ... & Bhattacharya, P. (2023). Inosine attenuates post-stroke neuroinflammation by modulating inflammasome mediated microglial activation and polarization. Biochimica et biophysica acta (BBA)-Molecular basis of disease, 1869(7), 166771.
8. Datta, A., Saha, C., Godse, P., Sharma, M., Sarmah, D., & Bhattacharya, P. (2023). Neuroendocrine regulation in stroke. Trends in Endocrinology & Metabolism, 34(5), 260-277.
9. Datta, A., Sarmah, D., Mounica, L., Kaur, H., Kesharwani, R., Verma, G., ... & Bhattacharya, P. (2020). Cell death pathways in ischemic stroke and targeted pharmacotherapy. Translational stroke research, 11(6), 1185-1202.
10. Datta, A., Sarmah, D., Kaur, H., Chaudhary, A., Mounica, K. L., Kalia, K., ... & Bhattacharya, P. (2022). Post-stroke impairment of the blood–brain barrier and perifocal vasogenic edema is alleviated by endovascular mesenchymal stem cell administration: modulation of the PKCδ/MMP9/AQP4-mediated pathway. Molecular neurobiology, 59(5), 2758-2775.